ATE490323T1 - Adiponektin-rezeptor und dafür kodierendes gen - Google Patents

Adiponektin-rezeptor und dafür kodierendes gen

Info

Publication number
ATE490323T1
ATE490323T1 AT03733398T AT03733398T ATE490323T1 AT E490323 T1 ATE490323 T1 AT E490323T1 AT 03733398 T AT03733398 T AT 03733398T AT 03733398 T AT03733398 T AT 03733398T AT E490323 T1 ATE490323 T1 AT E490323T1
Authority
AT
Austria
Prior art keywords
protein
adiponectin
binding ability
gene coding
adiponectin receptor
Prior art date
Application number
AT03733398T
Other languages
English (en)
Inventor
Takashi Kadowaki
Toshimasa Yamauchi
Ryozo Nagai
Jyunji Kamon
Original Assignee
Toudai Tlo Ltd
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toudai Tlo Ltd, Nissan Chemical Ind Ltd filed Critical Toudai Tlo Ltd
Application granted granted Critical
Publication of ATE490323T1 publication Critical patent/ATE490323T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Credit Cards Or The Like (AREA)
  • Manipulator (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
AT03733398T 2002-12-29 2003-06-12 Adiponektin-rezeptor und dafür kodierendes gen ATE490323T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002383738 2002-12-29
PCT/JP2003/007515 WO2004061108A1 (ja) 2002-12-29 2003-06-12 アディポネクチン受容体及びそれをコードする遺伝子

Publications (1)

Publication Number Publication Date
ATE490323T1 true ATE490323T1 (de) 2010-12-15

Family

ID=32708748

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733398T ATE490323T1 (de) 2002-12-29 2003-06-12 Adiponektin-rezeptor und dafür kodierendes gen

Country Status (7)

Country Link
US (4) US20040241802A1 (de)
EP (2) EP2141235B1 (de)
JP (1) JP3955885B2 (de)
AT (1) ATE490323T1 (de)
AU (1) AU2003242352A1 (de)
DE (1) DE60335216D1 (de)
WO (1) WO2004061108A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60335216D1 (de) 2002-12-29 2011-01-13 Nissan Chemical Ind Ltd Adiponektin-rezeptor und dafür kodierendes gen
WO2005031345A2 (en) * 2003-09-27 2005-04-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2)
JP5386056B2 (ja) 2003-11-04 2014-01-15 第一三共株式会社 抗腫瘍剤
EP1733733A1 (de) * 2004-03-04 2006-12-20 Takashi Kadowaki Regler für die adiponectin-rezeptor-expression
EP1757302B1 (de) * 2004-03-31 2016-10-05 Toudai Tlo, Ltd. Adiponectin-expressionsinduktor und seine verwendung
US7399742B2 (en) * 2004-07-23 2008-07-15 Depuy Spine, Inc. Anti-osteolytic therapy involving adiponectin
US20060069024A1 (en) * 2004-09-27 2006-03-30 Purdue Research Foundation Plant PR-5 proteins as mammalian therapeutic agents
US7678886B2 (en) * 2005-01-07 2010-03-16 Xencor, Inc. Pharmaceutical compositions of adiponectin variants and methods of storage
US7749956B2 (en) 2005-01-07 2010-07-06 Xencor, Inc. Method of treatment using adiponectin variants
JP2008526885A (ja) * 2005-01-07 2008-07-24 ゼンコア アディポネクチン変異体
US7592423B2 (en) * 2005-01-07 2009-09-22 Xencor, Inc. Globular adiponectin variants
US20070054359A1 (en) * 2005-07-11 2007-03-08 Jonathan Zalevsky Rational Chemical Modification of Adiponectin Variants
US8093017B2 (en) 2005-12-07 2012-01-10 Siemens Heathcare Diagnostics Inc. Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
WO2007125324A1 (en) * 2006-04-26 2007-11-08 Astrazeneca Ab Method of screening for an antagonist of adiponectin receptor 2 and uses thereof
JP2008109925A (ja) * 2006-10-04 2008-05-15 Japan Science & Technology Agency アディポネクチン受容体遺伝子欠損非ヒト動物及びその用途
EP2201371A4 (de) * 2007-09-24 2010-09-29 Univ Florida Testverfahren mit hohem durchsatz für inhibitoren und aktivatoren von paqr-rezeptoren
CA2707182C (en) 2007-11-30 2017-12-12 Siemens Healthcare Diagnostics Inc. Adiponectin receptor fragments and methods of use
EP2422199B1 (de) 2009-04-23 2018-07-25 Siemens Healthcare Diagnostics Inc. Monomere und dimere formen von adiponectin-rezeptorfragmenten sowie verwendungsverfahren dafür
US20110104666A1 (en) 2009-11-02 2011-05-05 Toshiya Matsubara Insulin resistance marker
JPWO2011115106A1 (ja) * 2010-03-16 2013-06-27 国立大学法人 東京大学 擬似運動療法のための医薬
JP5048100B2 (ja) * 2010-04-28 2012-10-17 シャープ株式会社 アディポネクチンに対する結合性を有するペプチド、ならびに該ペプチドを用いた分析方法および分析装置
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US20210139846A1 (en) * 2017-06-02 2021-05-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Engineered cells, and methods of using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1993002227A1 (en) 1991-07-15 1993-02-04 Eco-Tec Limited Process and apparatus for treating fluoride containing acid solutions
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
EP0822830B1 (de) 1995-04-27 2008-04-02 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US20040067490A1 (en) * 2001-09-07 2004-04-08 Mei Zhong Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2002191363A (ja) * 1999-07-29 2002-07-09 Herikkusu Kenkyusho:Kk 全長ｃＤＮＡ合成用プライマー、およびその用途
EP1074617A3 (de) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
CA2382015A1 (en) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Membrane associated proteins
CA2399776A1 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
DE60335216D1 (de) 2002-12-29 2011-01-13 Nissan Chemical Ind Ltd Adiponektin-rezeptor und dafür kodierendes gen
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US7435808B2 (en) * 2003-06-25 2008-10-14 Bristol-Myers Squibb Company Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2

Also Published As

Publication number Publication date
US7977459B2 (en) 2011-07-12
AU2003242352A8 (en) 2004-07-29
US20040241802A1 (en) 2004-12-02
US7501490B2 (en) 2009-03-10
WO2004061108A1 (ja) 2004-07-22
US8252584B2 (en) 2012-08-28
EP2141235A1 (de) 2010-01-06
DE60335216D1 (de) 2011-01-13
JPWO2004061108A1 (ja) 2006-05-11
US20070054314A1 (en) 2007-03-08
EP1589106A1 (de) 2005-10-26
AU2003242352A1 (en) 2004-07-29
EP1589106B1 (de) 2010-12-01
EP2141235B1 (de) 2014-06-11
US20100062541A1 (en) 2010-03-11
US20120027760A1 (en) 2012-02-02
JP3955885B2 (ja) 2007-08-08
EP1589106A4 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
AU2003242352A8 (en) Adiponectin receptor and gene coding for the same
DE60332320D1 (de) Neues screening-verfahren
EP1572967A4 (de) Auf il-1-rezeptor beruhende antagonisten sowie herstellungs- und verwendungsverfahren
ATE283365T1 (de) Il-1 rezeptor fusionsproteine verwendet als antagoniste und verfahren zu deren verwendung und herstellung
CY1112787T1 (el) Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17
DK1012274T3 (da) Dödsdomæneholdig receptor-4 (DR4: dödsreceptor 4), medlem af TNF-receptorsuperfamilien og som binder til TRAIL (Apo-2L)
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
AU2002328429A1 (en) CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
DE69836638D1 (de) Peptidanaloga abgeleitet vom tumornekrose-faktor-rezeptor
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
NO20003221L (no) Ny G-proteinkoblet reseptor
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60236921D1 (de) Verfahren und zusammensetzungen zur verwendung von mhc-klasse ii-invariante-kette-polypeptid als rezeptor für makrophagenwanderung-hemmfaktor
ATE353921T1 (de) Chimäre polypeptide, verfahren zur herstellung und verwendung dafür
DK1141286T3 (da) Kæde af cytokinreceptorer
DE60335726D1 (de) Chromoprotein und fluoroproteine
ATE424411T1 (de) Varianten von säugerprolactin
WO2000031262A3 (en) Human neurotensin subtype 2 receptor
ATE367438T1 (de) Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
ATE511644T1 (de) Neues screening-verfahren
EP1619499A4 (de) Neues screening-verfahren
DE602004023493D1 (de) Neues screening-verfahren
ATE447586T1 (de) Fprl1-liganden und deren verwendung
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ATE470858T1 (de) Opiatrezeptoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties